Development of a Monocentric and Prospective Clinical and Biological Database in Digestive Cancers, Gynecological Cancers, Breast Cancers and Sarcomas
The BCB is a tool: * for research in analytical and public health epidemiology, biological research and for the development of data useful for clinical research and therapeutic trials; * to help scientists understand and explain phenomena ranging from the interaction of molecules to the whole metabolism of the organism in normal and pathological situations; * to identify potential strategies for prevention, diagnosis, management and analysis of cancer subtypes. The creation of a broad clinical and biological prospective base dedicated to different types of cancer is essential for the development of such projects.
• Age\> at 18 years old,
• Patient with invasive or in situ tumor pathology (proven or suspected) any stage confounded,
• Patient in ICM at diagnosis
‣ a digestive cancer (esophagus, stomach, pancreas, colon, rectum, anal canal) or
⁃ gynecological cancer (ovary, endometrium, cervix) or
⁃ breast cancer or
⁃ sarcoma.
• Naïve patient of any treatment for the present cancer,
• Patient requiring treatment involving at least one (or more) tumor surgery (s)
• Patient who has accepted supplementary blood samples,
• Patient having given his informed, written and express consent.